Royal College of Surgeons in Ireland
Browse
The general practitioner-drug representative interaction.....pdf (100.46 kB)

The general practitioner-drug representative interaction: an ethical perspective

Download (100.46 kB)
journal contribution
posted on 2023-07-31, 12:50 authored by Martin Rourke

While the debate regarding the pharmaceutical representative-practitioner relationship is often an emotive one, it is clear that practitioners need the pharmaceutical industry to deliver new and better treatments. The doctor must acknowledge the potential of being subtly influenced by interaction with drug representatives and embrace ways to counterbalance it. Application of a simple ‘1:1 minute rule’ is one possible method to counteract potential for bias and enhance the relationship between the drug representative and the prescriber to the benefit of the patient.

History

Comments

The original article is available at http://www.rcsismj.com/ Part of the RCSsmj collection: https://doi.org/10.25419/rcsi.c.6767511.v1

Published Citation

Rourke M. The general practitioner-drug representative interaction: an ethical perspective. RCSIsmj. 2012;5(1):93-95

Publication Date

2012

Department/Unit

  • Undergraduate Research

Publisher

RCSI University of Medicine and Health Sciences

Version

  • Published Version (Version of Record)